Filing Flows › Elite Pharmaceuticals (ELTP) › Who owns the stock
Who owns Elite Pharmaceuticals (ELTP) stock
1 funds reported Elite Pharmaceuticals (ELTP) shares in their latest 13F filings, worth $365 in all. The largest holder is Kelleher Financial Advisors ($365). Last quarter 1 fund added to their stakes and 0 cut them.
Largest holders (13F)
| Fund | Shares | Value | Change | Quarter |
|---|---|---|---|---|
| Kelleher Financial Advisors | 1,000 | $365 | increase | 2026-06-30 |
Elite Pharmaceuticals' latest quarter
Elite Pharmaceuticals, Q1 FY27: revenue $32.4M (-20% year over year), operating margin 23.3%, net earnings $5.9M, operating cash flow $10.1M. The chart follows the revenue to costs, profit and cash.
Questions
Who owns the most ELTP stock?
By the latest 13F filings: Kelleher Financial Advisors ($365).
What is the short interest in ELTP?
3,034,556 shares were sold short at the 2026-10-15 settlement, 15.29% of the float.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.